-The Times of India JAIPUR: A doctor conducted drug trial on heart patients but seven of them died during trial of the drug. Moreover, another doctor conducted drug trials of different companies and 10 of his cancer patients died during the trials. An RTI filed by a government-run Indore hospital Dr Anand Rai exposed deaths leading to drug trials in entire country. Answering to the RTI, office ofdrug controller general, ministry of...
More »SEARCH RESULT
Total Matching Records found : 223
Drug prices set to fall by up to 80%-Rupali Mukherjee
-The Times of India MUMBAI: The government on Thursday issued the long-pending drug price control order, paving the way for the implementation of national pharmaceutical pricing policy, which will lead to a reduction in prices of medicines on an average by 20-25%, and in some life-saving ones, by up to 80%. Prices of 652 formulations under 27 therapeutic areas like anti-allergic (cetrizine), cardiac (aten), gastro-intestinal medicines (ocid), pain-killers ( paracetamol) and anti-diabetic...
More »Age of graft -CP Chandrasekhar
-Frontline Corruption tends to be greater in periods when there is a state-engineered redistribution of wealth in favour of a few at the explicit or implicit expense of the many. Liberalisation is one such period. IT cannot be verified and may not be true. But, the view that the record of graft and corruption during the two-term, nine-year rule of the United Progressive Alliance (UPA) is the worst in India's post-Independence...
More »Slow Poison-A Srinivas
-The Hindu Business Line Arsenic and fluoride contaminated water has condemned millions to live wasted lives in West Bengal, Andhra Pradesh and Karnataka. Business Line visited several villages in the affected regions for this special report by A. Srinivas. Sixty-nine-year-old Renubala Ari of Deganga village in West Bengal's North 24 Parganas district is counting her last days. But it is not her death that worries her. Blind in both eyes and with painful...
More »In the ‘pharmacy of the world’ -PT Jyothi Datta
-The Hindu Business Line From maker of versions of drugs, India's pharmaceutical industry has turned a top innovator Twenty years ago, Ranbaxy was a home-spun drug-maker. The Indian Patents Act allowed companies to make chemically-similar versions of innovative drugs. Visionaries in the pharmaceutical sector, like Parvinder Singh (Ranbaxy's key architect and member of its promoter family) and Anji Reddy (founder of Dr Reddy's Laboratories), were alive. And the pharmaceutical industry did not have...
More »
